Hidrasec

Hidrasec Dosage/Direction for Use

racecadotril

Manufacturer:

Abbott

Distributor:

Zuellig Pharma
Full Prescribing Info
Dosage/Direction for Use
Capsule: For oral use.
Adults: One capsule initially regardless of the time of day. Then, one capsule three times daily preferably before the main meals. Treatment should be continued until two normal stools are recorded.
Treatment should not exceed 7 days.
Long-term treatment with racecadotril is not recommended.
Special populations: Children: There are specific formulations intended for infants, children and adolescents.
Older people: Dosage adjustment is not necessary in the older people (see Pharmacology: Pharmacokinetics under Actions).
Caution is advised in patients with hepatic or renal impairment.
Granules for oral suspension: HIDRASEC INFANTS and HIDRASEC CHILDREN are administered via the oral route, together with oral rehydration (see Precautions).
Hidrasec Infants is intended for children <13 kg: The recommended dose is determined according to body weight: 1.5 mg/kg per dose (corresponding to 1 to 2 sachets), three times daily at regular intervals.
In infant less than 9 kg: one 10 mg sachet 3 times daily.
In infant from 9 kg to 13 kg: two 10 mg sachets 3 times daily.
Hidrasec Children 30 mg is intended for children ≥13 kg. The recommended dose is determined according to body weight: 1.5 mg/kg per dose (corresponding to 1 to 2 sachets), three times daily at regular intervals.
In children from 13 kg to 27 kg: one 30 mg sachet 3 times daily.
In children of more than 27 kg: two 30 mg sachets 3 times daily.
The duration of treatment in the clinical trials with children was 5 days. Treatment should be continued until two normal stools are recorded. Treatment should not exceed 7 days. Long-term treatment with racecadotril is not recommended.
There are no clinical trials in infants under 3 months of age.
Special populations: There are no studies in infants or children with renal impairment or hepatic impairment (see Precautions).
Caution is advised in patients with hepatic or renal impairment.
The granules can be added to food, dispersed in a glass of water or in the feeding-bottle, mixing well and followed by immediate administration.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in